Clopidogrel And Ticagrelor in Healthy Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Pharmacodynamics
Interventions
DRUG

Ticagrelor 90 mg

The subjects administer Ticagrelor 90 mg as loading dose (LD) follow by 90 mg/day as maintenance dose (MD) for 5 days, following a 2-week washout period, to receive the alternate thienopyridine (Clopidogrel 600 mg as LD follow by 75 mg/day as MD for 5 days).

DRUG

Clopidogrel 600 mg

The subjects administer Clopidogrel 600 as loading dose (LD) follow by 75 mg/day as maintenance dose (MD) for 5 days, following a 2-week washout period, to receive the alternate thienopyridine (Ticagrelor 90 mg/day as LD, follow by 90 mg/day as MD for 5 days).

Trial Locations (1)

602-715

Dong A University Hospital, Busan

All Listed Sponsors
lead

Dong-A University

OTHER

NCT02086903 - Clopidogrel And Ticagrelor in Healthy Subjects | Biotech Hunter | Biotech Hunter